T1	Participants 82 117	patients with interstitial cystitis
T2	Participants 328 349	interstitial cystitis
T3	Participants 435 451	patients with IC
T4	Participants 518 528	multicente
T5	Participants 620 644	placebo-controlled trial
T6	Participants 678 760	clinical National Institute of Diabetes and Digestive and Kidney Diseases criteria
T7	Participants 797 803	patien
T8	Participants 1033 1037	drug
T9	Participants 1210 1218	Eighteen
T10	Participants 1322 1341	42% for active drug
T11	Participants 1356 1359	GAR
T12	Participants 1475 1486	P = 0.0328)
T13	Participants 1700 1707	patient
T14	Participants 1625 1628	IC.
